Supernus Pharmaceuticals | SUPN - Credores Comerciais





Credores Comerciais Alterar Data
Abbott USD 4.68B 439M 2026-03
ANI Pharmaceuticals USD 73.83M 4.14M 2026-06
Aurora Cannabis CAD 9.31M 58.72M 2026-03
Bristol-Myers Squibb USD 4.16B 76M 2026-06
Canopy Growth CAD 34.82M 14.85M 2026-03
Cara Therapeutics USD 4.62M 1.4M 2026-03
Corcept Therapeutics USD 14.91M 18.4M 2026-06
Eisai JPY 87.53B 11.64B 2026-06
Eli Lilly USD 6.11B 1.08B 2026-06
Novo Nordisk DKK 14.59B 212M 2026-06
Pacira USD 17.51M 3.5M 2026-06
Perrigo USD 400.4M 34.4M 2026-06
Pfizer USD 4.58B 75M 2026-06
Supernus Pharmaceuticals USD 5.59M 4.58M 2026-06
United Therapeutics USD 497.8M 500K 2026-06
Xeris Pharmaceuticals USD 9.34M 2.13M 2026-06